Our Lines – P-CMRC

Available lines

nº	Name	Gender	Age	Cell Type	Reprogram. Method	Type	Disease	Mutation
nº	Name	Gender	Age	Cell Type	Reprogram. Method	Type	Disease	Mutation
1	KiPS3F-7	M	?	keratinocytes	integrative	retrovirus	control
2	KiPS4F-1	M	?	keratinocytes	integrative	retrovirus	control
3	KiPS4F-8	M	?	keratinocytes	integrative	retrovirus	control
4	cFA404-KiPS4F-1	M	?	keratinocytes	integrative	retrovirus	corrected Fanconi anemia
5	cFA404-KiPS4F-3	M	?	keratinocytes	integrative	retrovirus	corrected Fanconi anemia
6	XF-iPSF44-3F-1	M	3	fibroblasts	integrative	retrovirus	control
7	XF-iPSF44-3F-2	M	3	fibroblasts	integrative	retrovirus	control
8	[GA]FiPS4F	F	?	fibroblasts	integrative	retrovirus	Glutaril aciduria dehidrog. defic.
9	HKiPS4F	F	30	hair keratinocytes	integrative	retrovirus	control
10	CBiPS6-2F-4	M	0	CD133+ cord blood	integrative	retrovirus	control
11	CBiPS30-4F-3	M	0	CD133+ cord blood	integrative	retrovirus	control
12	CBiPS30-4F-5	M	0	CD133+ cord blood	integrative	retrovirus	control
13	CBiPS32-2F-2	F	0	CD133+ cord blood	integrative	retrovirus	control
14	FiPS-3F-1	M	3	fibroblasts	integrative	retrovirus	control
15	CBiPS32-3F-10	F	0	CD133+ cord blood	integrative	retrovirus	control
16	CBiPS32-3F-12	F	0	CD133+ cord blood	integrative	retrovirus	control
17	[CRTRd]FiPS3067-4F-9	M	adult	fibroblasts	integrative	retrovirus	Creatine Deficiency Syndrome	gene CRTR, c.1631 C>T
18	[CRTRd]FiPS3819-4F-2	M	adult	fibroblasts	integrative	retrovirus	Creatine Deficiency Syndrome	gene CRTR, c.1396 G>A
19	[AD]FiPSAG07645-4F-17	F	adult	fibroblasts	integrative	retrovirus	Alzheimer disease	gene PSEN1, A246E
20	[PD] FiPS022-V4F-15	M	?	fibroblasts	integrative	retrovirus	Parkinson disease	gene LRKK2 G2019S heterozygote with early onset PD (40)
21	[GD]FiPS-4F-21c	F	?	fibroblasts	integrative	lentivirus	Gaucher disease	gene GBA1, 721 G→A, 1448 T→C
22	[TSD] FiPS-4F-3-1	M	?	fibroblasts	integrative	retrovirus	Tay-Sachs disease	gene HEXA, heterozygote mutation c.1260G> C, c.1330 +1 G> A
23	FiPS-4F-7	M	3	fibroblasts	integrative	retrovirus	control
24	FiPS-4F-8	M	3	fibroblasts	integrative	retrovirus	control
25	[ctrl.PD]FiPS005-4F-9	F	56	fibroblasts	integrative	retrovirus	control (sister Parkinson disease)	control of [PD]FiPS006-4F-11
26	[PD]FiPS031-4F-1	M	48	fibroblasts	integrative	retrovirus	Parkinson disease	gene SNCA, A53T
27	[PD]FiPS006-4F-11	F	53	fibroblasts	integrative	retrovirus	Parkinson disease	gene PINK1, Q456Xhom
28	CBiPS 2F-1c	F	0	CD133+ cord blood	integrative	retrovirus	control
29	CBiPS 4F-10	F	0	CD133+ cord blood	integrative	retrovirus	control
30	CBiPS 4F-3a	F	0	CD133+ cord blood	integrative	retrovirus	control
31	FiPS Ctrl1-Ep6F-5	M	9	fibroblasts	not integrative	episomal	control
32	FiPS Ctrl2-Ep6F-8	M	2.5	fibroblasts	not integrative	episomal	control
33	FiPS Ctrl1-mR5F-6	M	9	fibroblasts	not integrative	mRNA	control
34	FiPS Ctrl2-mR5F-6	M	2.5	fibroblasts	not integrative	mRNA	control
35	FiPS Ctrl1-SV4F-7	M	9	fibroblasts	not integrative	Sendai virus	control
36	FiPS Ctrl2-SV4F-1	M	2.5	fibroblasts	not integrative	Sendai virus	control
37	FiPS Ctrl2-R4F-5	M	2.5	fibroblasts	integrative	retrovirus	control
38	FiPS Ctrl1-R4F-4	M	9	fibroblasts	integrative	retrovirus	control
39	UCiPS Ctrl5-R4F-25	F	58	urine cells	integrative	retrovirus	control
44	[MS] FiPS1-R4F-3	F	8	fibroblasts	integrative	retrovirus	multiple sclerosis	TT genotype of the TNFRSF1A polymorphism rs1800693
45	[MS] FiPS2-R4F-10	M	44	fibroblasts	integrative	retrovirus	multiple sclerosis	TT genotype of the TNFRSF1A polymorphism rs1800693
46	[MS] FiPS3-R4F-1	M	41	fibroblasts	integrative	retrovirus	multiple sclerosis	CC genotype of the TNFRSF1A polymorphism rs1800693
47	[MS] FiPS4-R4F-1	F	49	fibroblasts	integrative	retrovirus	multiple sclerosis	CC genotype of the TNFRSF1A polymorphism rs1800693
48	[MS] FiPS5-R4F-6	F	42	fibroblasts	integrative	retrovirus	multiple sclerosis	TT genotype of the TNFRSF1A polymorphism rs1800693
49	[MS] FiPS6-R4F-2	F	49	fibroblasts	integrative	retrovirus	multiple sclerosis	CC genotype of the TNFRSF1A polymorphism rs1800693
50	[DUPSW]FiPS301-R4F-1	F	15	fibroblasts	integrative	retrovirus	Williams-Beuren syndrome	7q.11.23 deletion
51	[DUP7]FiPS4-R4F-2	F	13	fibroblasts	integrative	retrovirus	Autism	7q.11.23 duplication
52	[SWB]FiPS1-R4F-5	F	15	fibroblasts	integrative	retrovirus	Williams-Beuren syndrome	7q.11.23 deletion
53	[SWB]FiPS5-R4F-1	F	15	fibroblasts	integrative	retrovirus	Williams-Beuren syndrome	7q.11.23 deletion
54	[AS] FiPS1-Ep6F-2	F	25	fibroblasts	not integrative	episomal	Alport sindrome	gene COL4A3, c.[345delG]; [345delG], p.[P116Lfs*37], Exon6
55	[AS] FiPS2-Ep6F-28	M	25	fibroblasts	not integrative	episomal	Alport sindrome	gene COL4A5, c3722G>A (G1241D)
56	[AS] FiPS3-Ep6F-9	M	41	fibroblasts	not integrative	episomal	Alport sindrome	gene COL4A5, c4034G>A (G1345D)
57	[IDDM-1] FiPS 1-13 - Ep6F-9	M	38	fibroblasts	not integrative	episomal	Diabetes
58	SWB FiPS 159-R4F-4	M	14	fibroblasts	integrative	retrovirus	Williams-Beuren syndrome	7q11.23 deletion
59	SWB FiPS 344-R4F-2	M	7	fibroblasts	integrative	retrovirus	Williams-Beuren syndrome	7q11.23 deletion
60	DUPSW FiPS 501-R4F-2	M	17	fibroblasts	integrative	retrovirus	Autism	7q11.23 duplication
61	DUPSW FiPS701 R4F-6	M	4	fibroblasts	integrative	retrovirus	Autism	7q11.23 duplication
65	OCD FiPS1-Ep6F-16	F	54	fibroblasts	not integrative	episomal	Obssesive compulsive diorder
66	OCD FiPS2-Ep6F-10	F	51	fibroblasts	not integrative	episomal	Obssesive compulsive diorder
67	BST PBiPS1-Sv4F-1	F	52	Perif. blood monon. cells	not integrative	Sendai virus	rare bood type	fenotype vel negative
68	BST PBiPS2-Sv4F-6	M	62	Perif. blood monon. cells	not integrative	Sendai virus	control rare blood types
73	CT PBiPS1-Sv4F-1	M	7	Perif. blood monon. cells	not integrative	Sendai virus	Cardiotoxicity to anthracyclines

Our current QC process include tests for: 

Purity- Mycoplasma contamination
Identity- Short Tandem Repeats (STR)
Stability- Karyotyping
Stemness: absence of reprogramming factors, pluripotent gene expression, and differentiation capacity

How to request hPSC lines

Requests for cell lines must first be authorized by an Ethics Committee and Comisión de Garantías para la Donación y Utilización de Células y Tejidos Humanos del Insitiuto de Salud Carlos III.

Request of Generation of iPSC I:

Request of Generation of iPSC II (Donors):

Name	Karyotype	Comments
Name	Karyotype	Comments
ES[2]	46,XY
ES[3]	46,XY
ES[4]	46,XY
ES[5]	46,XY
ES[6]	46,XY
ES[7]	46,XY
ES[8]	46,XY
ES[9]	46,XY
ES[10]	46, XX
ES[11-EM]	46, XY	c.484delC in the exon 2 of the gen EXT2 responsible of the multiple exostosis type 2
pES[12]	46, XX	hESc line derivated from a parthenogenetic embryo
bES[13]	46, XX	hESC line derivated from a single blastomere
			html l